Published in Blood on April 01, 1980
Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol (1987) 5.23
Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proc Natl Acad Sci U S A (1982) 1.64
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest (1985) 1.57
Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A (1998) 1.23
Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest (1981) 1.09
Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clin Invest (1996) 0.99
Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Br J Pharmacol (1990) 0.97
Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog. Br J Pharmacol (1991) 0.91
Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation. Br J Pharmacol (1989) 0.88
Nitric oxide function in atherosclerosis. Mediators Inflamm (1997) 0.87
Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells. Br J Pharmacol (1993) 0.86
Nitrates. Mode of action at a cellular level. Drugs (1987) 0.79
Effects of a selective thromboxane receptor antagonist (GR32191B) and of glyceryl trinitrate on bleeding time in man. Br J Clin Pharmacol (1990) 0.78
Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers. Br J Clin Pharmacol (1993) 0.77
Effect of storage on levels of nitric oxide metabolites in platelet preparations. Transfusion (2012) 0.77
Inhibition of platelet aggregation by transdermal glyceryl trinitrate. Br Heart J (1994) 0.75
Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog. Basic Res Cardiol (1985) 0.75
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res (1994) 8.57
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med (1986) 6.05
Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science (1985) 5.23
Platelets and shear stress. Blood (1996) 4.18
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med (1995) 3.32
Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest (1993) 2.97
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med (1987) 2.83
Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res (1998) 2.70
Optical properties of the metals Al, Co, Cu, Au, Fe, Pb, Ni, Pd, Pt, Ag, Ti, and W in the infrared and far infrared. Appl Opt (1983) 2.65
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (1991) 2.53
Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem (1999) 2.46
Gastroesophageal reflux-induced bronchoconstriction. Is microaspiration a factor? Chest (1995) 2.40
Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res (1998) 2.37
Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol (1986) 2.35
Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem (1986) 2.33
Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res (1986) 2.32
Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science (1975) 2.24
Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol (1982) 2.22
Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications. Arch Intern Med (1996) 2.20
Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol (1990) 2.11
Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest (1992) 2.10
p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem (1998) 2.07
Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature (1987) 2.04
Optical properties of fourteen metals in the infrared and far infrared: Al, Co, Cu, Au, Fe, Pb, Mo, Ni, Pd, Pt, Ag, Ti, V, and W. Appl Opt (1985) 2.04
Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med (1981) 1.97
Purification and binding properties of human platelet factor four. J Biol Chem (1976) 1.94
Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol (1995) 1.93
Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum (1997) 1.92
Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science (1986) 1.91
Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J Clin Invest (1984) 1.88
Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation (2001) 1.88
Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem (1989) 1.83
The hypercoagulable states. Ann Intern Med (1985) 1.80
Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum (1996) 1.77
Bleeding and thrombosis in the myeloproliferative disorders. Blood (1984) 1.74
Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation (1988) 1.69
Biochemical mechanisms of platelet activation. Blood (1989) 1.65
Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J (1998) 1.65
Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A (1996) 1.64
Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest (1995) 1.63
Vasoconstriction: a new activity for platelet-derived growth factor. Science (1986) 1.61
Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res (1998) 1.60
Inflammation and coronary artery disease. N Engl J Med (1994) 1.58
Characterization of a new megakaryocytic cell line: the Dami cell. Blood (1988) 1.58
Phorbol ester and 1-oleoyl-2-acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells. J Biol Chem (1985) 1.57
Retracted Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2001) 1.55
Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol (1987) 1.53
Retracted Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem (2001) 1.53
Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation (1989) 1.52
Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum (1997) 1.51
Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding. Proc Natl Acad Sci U S A (1975) 1.49
Platelets and coronary artery disease. N Engl J Med (1996) 1.47
Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension (1997) 1.45
Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. Am J Cardiol (1994) 1.45
Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J Biol Chem (1996) 1.45
Molecular biology of the renin-angiotensin system. Circulation (1993) 1.44
The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell (1988) 1.44
Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain. J Biol Chem (2000) 1.43
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation (1990) 1.42
Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis (2001) 1.41
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest (1991) 1.41
DAMI cell line. Blood (1997) 1.41
Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation (1993) 1.40
Direct identification and characterisation of beta-adrenergic receptors in rat brain. Nature (1975) 1.40
Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation (1999) 1.40
Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension (1997) 1.39
Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res (1997) 1.39
Two TaqI polymorphisms in the 5' region of the von Willebrand factor (vWF) gene. Nucleic Acids Res (1989) 1.38
Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension (1998) 1.37
Identification of platelet receptors for prostaglandin I2 and D2. J Biol Chem (1979) 1.36
Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med (1996) 1.36
Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation (1995) 1.35
Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med (1981) 1.33
Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. J Biol Chem (1989) 1.32
Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J Clin Invest (1974) 1.32
Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol (1996) 1.31
Angiotensin II-stimulated Na+/H+ exchange in cultured vascular smooth muscle cells. Evidence for protein kinase C-dependent and -independent pathways. J Biol Chem (1987) 1.31
Extrapancreatic, extraintestinal gastrinoma: effective treatment by surgery. N Engl J Med (1982) 1.31
Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum (1995) 1.28
Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest (1989) 1.27
The study of the influence of flow on vascular endothelial biology. Am J Med Sci (1998) 1.26
Heterogeneity of myosin antigenic expression in vascular smooth muscle in vivo. Lab Invest (1984) 1.26
Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids. Circ Res (1974) 1.25
Regulation by angiotensin II of its receptors in resistance blood vessels. Nature (1980) 1.24
Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. Hypertension (1985) 1.24
Native conformation of human von Willebrand protein. Analysis by electron microscopy and quasi-elastic light scattering. J Biol Chem (1985) 1.24
Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. J Immunol (1987) 1.23
Oxidative stress and cardiovascular disease. Circulation (1997) 1.23
Postpartum hemolytic uremic syndrome. Obstet Gynecol (1976) 1.23
Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol (1993) 1.23
Characterization of phosphatidylinositol-specific phospholipase C from cultured vascular smooth muscle cells. J Biol Chem (1991) 1.22
Early agonist-mediated ionic events in cultured vascular smooth muscle cells. Calcium mobilization is associated with intracellular acidification. J Biol Chem (1987) 1.22
Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides. J Biol Chem (1995) 1.21
Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J Biol Chem (1987) 1.19
Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation (2001) 1.19
Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest (1997) 1.19
The prethrombotic state in cancer. Semin Oncol (1990) 1.19
YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochem Biophys Res Commun (2000) 1.19